The Southeast Biotech Collaborative (SEBC) brings together an unprecedented breadth of researchers, innovators and entrepreneurs, established biotech companies, investors, governments, workforce and economic development leaders, and others throughout the Southeast U.S. to collaborate, innovate, and deliver biotechnologies that meet commercial needs faster.
The Southeast Biotech Collaborative (SEBC) is accelerating and deploying technological advancement in biomanufacturing, biologistics, and precision population health for next-generation competitiveness in healthcare and health products.
We are a consortium of universities and companies with over $500 million in assets, that, over the next eight years, will grow to deliver the following results through focus on biotechnologies that can be commercialized in less than a decade.
The SEBC aims to capitalize on the region’s key assets and critical expertise in biomanufacturing that can be expanded and leveraged in a more integrated private-public ecosystem. The SEBC will ensure a robust, well-trained workforce and production capacity that grows domestic manufacturing capabilities and helps reduce the dependence on foreign suppliers.
The Southeast is the logistics epicenter of the world. Drug and device shortages and supply chain disruptions present pressing challenges to U.S. national and economic security. Leveraging the logistical, agricultural production, and bioengineering strengths of the region, we can onshore the manufacturing of key technologies, enhance the U.S. domestic supply chain, and expand our biologistics capabilities.
The SEBC will take on the Southeast’s and the nation’s biggest challenges by delivering technological solutions to ensure next-generation production capacity for the future of precision medicine. By combining the knowledge, training, and resources of our partners, the SEBC will create a synergistic capacity to speed and scale the development and commercialization of the Southeast’s existing base of cutting-edge biomedical, biomaterials, and bioengineering research.